BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3375980)

  • 1. [Hyperfractionated irradiation of esophageal cancer. Initial results of a pilot study].
    Schnabel K; Berberich W; Niewald M; Tkocz HJ; Scharding B
    Strahlenther Onkol; 1988 May; 164(5):266-9. PubMed ID: 3375980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The combined radiochemotherapy of inoperable esophageal neoplasms: a feasibility study].
    Sola B; Airoldi M; Orecchia R; Rovea P; Fracchia F; Boidi Trotti A; Tessa M; Foco A; Oliaro A; Casadio C; Dei Poli M
    Radiol Med; 1996 Apr; 91(4):456-9. PubMed ID: 8643859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
    Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
    Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiation therapy and treatment results in carcinoma of the esophagus (author's transl)].
    Wieland C; Hymmen U
    Strahlentherapie; 1977 Nov; 153(11):719-25. PubMed ID: 337587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperfractionated irradiation of non-small cell bronchial cancer. Final results of a Phase II study].
    Berberich W; Bier B; Schnabel K; Schlimmer P
    Strahlenther Onkol; 1993 Aug; 169(8):469-75. PubMed ID: 8395087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of multimodality treatment of locoregional esophageal carcinoma by Southwest Oncology Group 9060.
    Poplin EA; Jacobson J; Herskovic A; Panella TJ; Valdivieso M; Hutchins LF; Macdonald JS
    Cancer; 1996 Nov; 78(9):1851-6. PubMed ID: 8909302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of locally advanced esophageal cancer by combined intralumenal brachytherapy and external beam radiotherapy].
    Mileusnić D; Durbaba M; Vucićević S; Stanković J; RadosevićJelić Lj; Pekmezović T
    Srp Arh Celok Lek; 1995; 123(9-10):254-7. PubMed ID: 17974443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma.
    Pasquier D; Mirabel X; Adenis A; Rezvoy N; Hecquet G; Fournier C; Coche-Dequeant B; Prevost B; Castelain B; Lartigau E
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1456-61. PubMed ID: 16863928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multifractionated radiotherapy of esophageal cancer].
    Leskov VP; Larin BS
    Med Radiol (Mosk); 1989 Mar; 34(3):11-4. PubMed ID: 2927270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The dose of radiotherapy in esophageal cancer combined with external beams and intracavitary radium brachytherapy].
    Nishio M; Sakurai T; Kagami Y; Narimatsu N; Ibayashi J; Hareyama M
    Gan No Rinsho; 1987 Mar; 33(3):242-8. PubMed ID: 3586340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study.
    Zhao KL; Shi XH; Jiang GL; Yao WQ; Guo XM; Wu GD; Zhu LX
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1014-20. PubMed ID: 15990003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.
    Brunner TB; Rupp A; Melzner W; Grabenbauer GG; Sauer R
    Strahlenther Onkol; 2008 Jan; 184(1):15-22. PubMed ID: 18188518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207).
    Gaspar LE; Winter K; Kocha WI; Pinover WH; Herskovic ; Graham M; Gunderson L
    Cancer J; 2001; 7(5):388-94. PubMed ID: 11693897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Curative treatment of non-metastatic esophageal cancer: concomitant chemoradiotherapy and high-dose-rate endoluminal curietherapy boost].
    Taieb S; Vaillant E; Pommier P; Bonvoisin S; Desseigne F; Morignat E; Gerard JP; Mornex F
    Gastroenterol Clin Biol; 1999 Oct; 23(10):1048-54. PubMed ID: 10592877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma.
    Czito BG; Cohen DP; Kelsey CR; Lockhart AC; Bendell JC; Willett CG; Petros WP; D'Amico TA; Truax R; Hurwitz HI
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1066-72. PubMed ID: 17881149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-course accelerated hyperfractionated radiotherapy for localized esophageal carcinoma.
    Zhao KL; Shi XH; Jiang GL; Wang Y
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):123-9. PubMed ID: 15337547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
    Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
    Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
    Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.